Skip to content
10-Q

Quarterly Report

XG SCIENCES INC

0001731122-20-000655

← back to feed
Filed
Jun 17, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Jun 15, 2020 3.95M sh
Capex Q1 2020 · Mar 31, 2020 $6.29K
Capex Q1 2020 · Mar 31, 2019 $217.02K
Operating Cash Flow Q1 2020 · Mar 31, 2020 −$1.63M
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$1.84M
Long Term Debt Q1 2020 · Mar 31, 2020 $9.22M
Long Term Debt Q1 2020 · Dec 31, 2019 $8.11M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $458.85K
Cash And Equivalents Q1 2020 · Dec 31, 2019 $1.13M
Cash And Equivalents Q1 2020 · Mar 31, 2019 $3.03M
Cash And Equivalents Q1 2020 · Dec 31, 2018 $4.89M
Stockholders Equity Q1 2020 · Mar 31, 2020 −$4.32M
Stockholders Equity Q1 2020 · Dec 31, 2019 −$2.15M
Stockholders Equity Q1 2020 · Mar 31, 2019 $3.18M
Stockholders Equity Q1 2020 · Dec 31, 2018 $4.99M
Current Liabilities Q1 2020 · Mar 31, 2020 $1.61M
Current Liabilities Q1 2020 · Dec 31, 2019 $1.39M
Total Liabilities Q1 2020 · Mar 31, 2020 $11.87M
Total Liabilities Q1 2020 · Dec 31, 2019 $10.69M
Current Assets Q1 2020 · Mar 31, 2020 $1.77M
Current Assets Q1 2020 · Dec 31, 2019 $2.43M
Total Assets Q1 2020 · Mar 31, 2020 $7.56M
Total Assets Q1 2020 · Dec 31, 2019 $8.54M
Sga Expense Q1 2020 · Mar 31, 2020 $1.29M
Sga Expense Q1 2020 · Mar 31, 2019 $1.42M
Rd Expense Q1 2020 · Mar 31, 2020 $285.73K
Rd Expense Q1 2020 · Mar 31, 2019 $385.25K
Net Income Q1 2020 · Mar 31, 2020 −$2.35M
Net Income Q1 2020 · Mar 31, 2019 −$2.2M
Operating Income Q1 2020 · Mar 31, 2020 −$2.17M
Operating Income Q1 2020 · Mar 31, 2019 −$2.12M
Gross Profit Q1 2020 · Mar 31, 2020 −$595.42K
Gross Profit Q1 2020 · Mar 31, 2019 −$317.34K
Cost Of Revenue Q1 2020 · Mar 31, 2020 $762.48K
Cost Of Revenue Q1 2020 · Mar 31, 2019 $1.17M
Revenue Q1 2020 · Mar 31, 2020 $167.06K
Revenue Q1 2020 · Mar 31, 2019 $857.28K